Development of sebaceous carcinoma in a patient on ruxolitinib therapy.

Mohsin, Noreen; Whitecar, Scott B; Jones, Jacqueline; Childs, John M; Brownell, Isaac

Mohsin, Noreen; Whitecar, Scott B; Jones, Jacqueline; Childs, John M; Brownell, Isaac.

Afiliación

Mohsin N; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
Whitecar SB; Walter Reed National Military Medical Center, Bethesda, Maryland.
Jones J; Walter Reed National Military Medical Center, Bethesda, Maryland.
Childs JM; Walter Reed National Military Medical Center, Bethesda, Maryland.
Brownell I; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

JAAD Case Rep ; 26: 17-19, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35846389

Palabras clave

JAK, Janus kinase; Janus kinase inhibitor; NMSC, nonmelanoma skin cancer; SC, sebaceous carcinoma; SCC, squamous cell carcinoma; jakinib; ruxolitinib; sebaceous carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Case Rep Año: 2022 Tipo del documento: Article